Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS)
DIAMOnDS
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will investigate the link between the gut microbiota, the occurrence of the central adiposity phenotype, and the patients' fear to regain weight in anorexia nervosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedStudy Start
First participant enrolled
February 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2028
November 14, 2025
November 1, 2025
4.6 years
September 4, 2023
November 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Identification of gut microbiota biomarkers - composition
Species-level taxonomic profile and functional potential of the gut microbiota generated by shotgun metagenomics performed on stool samples collected at inclusion, between those who express or not the central adiposity phenotype.
At inclusion
Identification of gut microbiota biomarkers - diversity and richness
α-diversity, β-diversity, richness in genes, richness in species and enterotype of the gut microbiota generated by shotgun metagenomics performed on stool samples collected at inclusion, between those who express or not the central adiposity phenotype
At inclusion
Identification of gut microbiota biomarkers - metabolites
Levels of Short Chain Fatty Acids (SCFAs) (acetate, propionate, butyrate, valerate, isobutyrate and isovalerate) produced by the gut microbiota estimated through gas chromatography-mass spectrometry on blood and stool samples collected at inclusion, between those who express or not the central adiposity phenotype.
At inclusion
Secondary Outcomes (7)
Identification of the central adiposity phenotype
At inclusion
Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - composition
At inclusion
Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - diversity and richness
At inclusion
Characterisation of gut microbiota biomarkers of patients with severe to extreme anorexia nervosa - metabolites
At inclusion
Variation of the composition of the gut microbiota between admission and discharge
At discharge, anticipated average 10 weeks
- +2 more secondary outcomes
Study Arms (1)
Anorexia nervosa
EXPERIMENTALInterventions
Clinical and biological measurements, blood and stool sample collection
Eligibility Criteria
You may qualify if:
- Women
- Over 15 years old and 3 months.
- Admitted in the specialized department for eating disorders of CHU Nantes for refeeding.
- With a diagnosis of anorexia nervosa at admission (restrictive or Binge-Eating-Purging type).
- Body Mass Index at admission below 16 kilogram per square meter.
- Written informed consent for patients over 18 years old/ oral informed consent from both the patient and a legal representative for patients under 18 years old.
- Affiliated with French social security system or beneficiary from such system.
You may not qualify if:
- Pregnant and breastfeeding women.
- Who received a treatment with antibiotic/antifungal (other than local application) in the last three months.
- Who had a weight gain in the last month (5% or more of the patient's weight at admission).
- Under trusteeship or guardianship.
- Not fluent in French
- Who participate in another interventional study involving medication.
- Patients for whom stool collection or body mass composition analysis (with Dual-energy X-ray absorptiometry) couldn't be done during the first week of hospitalisation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- Fondation de Francecollaborator
Study Sites (1)
Nantes University Hospital
Nantes, 44093, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2023
First Posted
September 21, 2023
Study Start
February 22, 2024
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
September 30, 2028
Last Updated
November 14, 2025
Record last verified: 2025-11